Clinical and Translational Gastroenterology

Title Publication Date Language Citations
Improvement in Esophageal Distensibility in Response to Medical and Diet Therapy in Eosinophilic Esophagitis2017/10/01English72
SPINK1 , PRSS1 , CTRC , and CFTR Genotypes Influence Disease Onset and Clinical Outcomes in Chronic Pancreatitis2018/11/01English70
Expression Profiles of miRNA Subsets Distinguish Human Colorectal Carcinoma and Normal Colonic Mucosa2016/03/01English69
C. difficile Infection: Changing Epidemiology and Management Paradigms2015/07/01English69
Topical Steroid Therapy for the Treatment of Eosinophilic Esophagitis (EoE): A Systematic Review and Meta-Analysis2015/03/01English68
Targeting the vasculature in hepatocellular carcinoma treatment: Starving versus normalizing blood supply2017/06/01English68
A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia2016/01/01English67
The Effects of Bowel Preparation on Microbiota-Related Metrics Differ in Health and in Inflammatory Bowel Disease and for the Mucosal and Luminal Microbiota Compartments2016/02/01English66
Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis2018/09/01English64
Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota Composition2016/08/01English64
Prevalence of Different Subtypes of Serrated Polyps and Risk of Synchronous Advanced Colorectal Neoplasia in Average-Risk Population Undergoing First-Time Colonoscopy2012/01/01English64
Diminishing Effectiveness of Long-Term Maintenance Topical Steroid Therapy in PPI Non-Responsive Eosinophilic Esophagitis2017/06/01English63
Colonoscopy: Quality Indicators2015/02/01English63
Diagnostic Accuracy of Methylated SEPT9 for Blood-based Colorectal Cancer Detection: A Systematic Review and Meta-Analysis2017/01/01English63
Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome2016/05/01English62
Genetic risk, dysbiosis, and treatment stratification using host genome and gut microbiome in inflammatory bowel disease2018/01/01English62
Higher Activity of the Inducible Nitric Oxide Synthase Contributes to Very Early Onset Inflammatory Bowel Disease2014/01/01English61
BARHL2 Methylation Using Gastric Wash DNA or Gastric Juice Exosomal DNA is a Useful Marker For Early Detection of Gastric Cancer in an H. pylori -Independent Manner2016/07/01English60
Metabolic Profiling of the Impact of Oligofructose-Enriched Inulin in Crohn's Disease Patients: A Double-Blinded Randomized Controlled Trial2013/01/01English60
Butyrate and Mucosal Inflammation: New Scientific Evidence Supports Clinical Observation2015/08/01English59
Impact of Dietary Lipids on Colonic Function and Microbiota: An Experimental Approach Involving Orlistat-Induced Fat Malabsorption in Human Volunteers2016/04/01English58
The Association Between IGF-1 Levels and the Histologic Severity of Nonalcoholic Fatty Liver Disease2017/01/01English57
Characteristics of the bacterial microbiome in association with common intestinal parasites in irritable bowel syndrome2018/06/01English56
Colon Tuberculosis: Endoscopic Features and Prospective Endoscopic Follow-Up After Anti-Tuberculosis Treatment2012/10/01English54
Marked Elevation of Lipase in COVID-19 Disease: A Cohort Study2020/07/01English53
Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?2015/10/01English53
Fibroblast Growth Factor 19 and 7α-Hydroxy-4-Cholesten-3-one in the Diagnosis of Patients With Possible Bile Acid Diarrhea2012/07/01English52
Dual TNF-α/Cyclin D1 Gene Silencing With an Oral Polymeric Microparticle System as a Novel Strategy for the Treatment of Inflammatory Bowel Disease2011/03/01English52
Risk of thrombosis and mortality in inflammatory bowel disease2018/04/01English50
The Common Chymotrypsinogen C ( CTRC ) Variant G60G (C.180T) Increases Risk of Chronic Pancreatitis But Not Recurrent Acute Pancreatitis in a North American Population2015/01/01English50